Haemonetics reported $855.53M in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Baxter International USD 6.83B 163M Sep/2026
Becton, Dickinson and Co. USD 8.32B 178M Sep/2026
Boston Scientific USD 8.16B 192M Sep/2026
Cerus USD 174.38M 7.26M Dec/2025
Cooper Companies USD 2.28B 18.3M Jun/2026
Fresenius EUR 12.29B 678M Sep/2026
Fresenius Medical Care EUR 7.84B 150.6M Sep/2026
Globus Medical USD 2.18B 33.55M Sep/2026
Haemonetics USD 855.53M 44.7M Sep/2026
ICU Medical USD 1.22B 8.96M Sep/2026
Intuitive Surgical USD 10.65B 1.68B Sep/2026
Medtronic USD 24.39B 397M Jun/2026
Merit Medical Systems USD 1.2B 86.58M Sep/2026
Neogen USD 582.5M 22.1M Jun/2026
OraSure Technologies USD 222.94M 17.84M Jun/2026
Plus Therapeutics USD 11.77M 6.26M Jun/2026
Quidel USD 1.45B 69.4M Sep/2026
ResMed USD 3.51B 815.82M Sep/2026
STAAR Surgical USD 353.43M 11.08M Sep/2026
Steris USD 2.48B 33.4M Sep/2026
Stryker USD 14.18B 235M Sep/2026
Teleflex USD 1.84B 31.2M Sep/2026
Terumo JPY 877.74B 28.86B Sep/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
US Physical Therapy USD 154.76M 15.09M Sep/2026
Zimmer Biomet Holdings USD 5.13B 32.3M Sep/2026